Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/26/2025

Management of Hemoptysis in CTEPH

Definitive Treatment

  • Elective pulmonary endarterectomy (PEA) remains the definitive treatment for CTEPH, with nearly normalized pulmonary hemodynamics in most patients, according to the European Respiratory Review and European Heart Journal guidelines 2

Anticoagulation Management

  • The European Society of Cardiology recommends that all CTEPH patients require lifelong therapeutic anticoagulation with warfarin targeted to INR 2.0-3.0, as stated in the European Respiratory Review and European Heart Journal 3, 4, 5
  • After successful BAE, anticoagulation can be safely resumed or continued, as recommended by the American College of Chest Physicians, although the citation is from Praxis Medical Insights, an alternative source is not provided 2